Staar Surgical Co (STAA)
46.96
+0.07
(+0.15%)
USD |
NASDAQ |
Apr 26, 16:00
46.95
-0.01
(-0.02%)
After-Hours: 20:00
Staar Surgical SG&A Expense (Quarterly): 39.45M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 39.45M |
September 30, 2023 | 45.87M |
June 30, 2023 | 50.37M |
March 31, 2023 | 44.45M |
December 31, 2022 | 39.03M |
September 30, 2022 | 37.14M |
June 30, 2022 | 38.22M |
March 31, 2022 | 29.21M |
December 31, 2021 | 28.54M |
September 30, 2021 | 29.19M |
June 30, 2021 | 30.29M |
March 31, 2021 | 23.41M |
December 31, 2020 | 21.27M |
September 30, 2020 | 21.24M |
June 30, 2020 | 18.17M |
March 31, 2020 | 19.00M |
December 31, 2019 | 19.07M |
September 30, 2019 | 19.56M |
June 30, 2019 | 19.19M |
March 31, 2019 | 16.98M |
December 31, 2018 | 16.10M |
September 30, 2018 | 16.71M |
June 30, 2018 | 16.86M |
March 31, 2018 | 13.22M |
December 31, 2017 | 13.01M |
Date | Value |
---|---|
September 30, 2017 | 11.21M |
June 30, 2017 | 12.03M |
March 31, 2017 | 11.88M |
December 31, 2016 | 9.972M |
September 30, 2016 | 12.13M |
June 30, 2016 | 12.11M |
March 31, 2016 | 16.14M |
December 31, 2015 | 10.77M |
September 30, 2015 | 11.14M |
June 30, 2015 | 10.57M |
March 31, 2015 | 10.83M |
December 31, 2014 | 8.712M |
September 30, 2014 | 10.28M |
June 30, 2014 | 12.56M |
March 31, 2014 | 11.70M |
December 31, 2013 | 12.40M |
September 30, 2013 | 10.16M |
June 30, 2013 | 10.20M |
March 31, 2013 | 10.14M |
December 31, 2012 | 10.61M |
September 30, 2012 | 9.685M |
June 30, 2012 | 9.696M |
March 31, 2012 | 9.078M |
December 31, 2011 | 9.172M |
September 30, 2011 | 8.259M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
18.17M
Minimum
Jun 2020
50.37M
Maximum
Jun 2023
30.14M
Average
29.19M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Anika Therapeutics Inc | 20.34M |
The Cooper Companies Inc | 380.90M |
OrthoPediatrics Corp | 32.03M |
NexGel Inc | 1.22M |
Innovative Eyewear Inc | 2.160M |